MedPath

The study of the effects of melatonin on nocturnal blood pressure fluctuation in patients with obstructive sleep apnea

Phase 1
Recruiting
Conditions
Obstructive sleep apnea.
Obstructive sleep apnea (adult) (pediatric)
G47.33
Registration Number
IRCT20221023056278N1
Lead Sponsor
IMAD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Age between 18 and 75 years
Diagnosis of OSA [apnea-hypopnea index (AHI) =?15]
BP =?180/110 mmHg

Exclusion Criteria

Patients who have been hospitalized for cardiac or respiratory exacerbations less than 6 weeks prior to recruiting
Those with autonomic nervous system diseases or endocrine disorders which might influence BP
BP =?180/110 mmHg
Those unwilling to participate in the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Systolic and diastolic BP, serum ACE level and cortisol. Timepoint: Before and one month after the intervention. Method of measurement: Using polysomnography and laboratory evaluation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath